Indigenous Knowledge, Benefit Sharing and Biopiracy in Herbal Medicine
What biopiracy and benefit sharing mean in herbal medicine, what the Nagoya Protocol and the 2024 WIPO treaty say, and why respect for knowledge keepers matters.
Content last updated . This page has not been medically reviewed.
Safety first. Natural products can cause side effects and interact with medicines. Read herb safety and interactions before you use anything on this page.
Many herbal medicines begin with knowledge held by Indigenous Peoples and local communities. This page explains, in plain terms, the words used when that knowledge meets research, patents and commerce: traditional knowledge, genetic resources, benefit sharing and biopiracy. It describes what international agreements say. It does not recommend any plant and it is not legal advice.
How the sources define the terms
- Traditional medicine. The WHO describes it as codified or non-codified systems for healthcare and well-being, with practices, skills, knowledge and philosophies originating in different historical and cultural contexts. [1]
- Traditional knowledge. WIPO notes that many Indigenous Peoples, local communities and governments seek intellectual property protection for traditional knowledge, which it says ranges from traditional medicine to environmental knowledge, art, symbols and music. [2]
- Genetic resources. WIPO says genetic resources as such are not patentable but inventions based on them may be. [2]
- Benefit sharing. Under the Nagoya Protocol, sharing the benefits that arise when genetic resources are used for research, development and commercialization. Benefits may be monetary or non-monetary, such as royalties and the sharing of research results. [3]
- Biopiracy. A term used by researchers for using biological resources or the knowledge of Indigenous tribes or communities without letting them share the revenues or other benefits. [4] This page uses the wording of the sources cited. The authors of a later paper argue that using traditional knowledge without benefit sharing can be understood as a form of neocolonialism. [5]
What international agreements say
| Agreement | What the source says | Who wrote it |
|---|---|---|
| Nagoya Protocol (Convention on Biological Diversity) | Adopted 29 October 2010 and in force from 12 October 2014. It aims at fair and equitable sharing of benefits from the use of genetic resources. [3] | CBD Secretariat |
| Nagoya Protocol, traditional knowledge | It also covers traditional knowledge associated with genetic resources and the benefits arising from its use. [3] | CBD Secretariat |
| Nagoya Protocol, consent | It calls for clear rules on prior informed consent and mutually agreed terms. [3] For Indigenous and local communities with established rights to grant access, Parties are to take measures to ensure those communities' prior informed consent and fair and equitable benefit sharing. [3] | CBD Secretariat |
| WIPO Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge | Adopted in May 2024; WIPO says it is the first WIPO treaty on this interface and the first to include provisions specifically for Indigenous Peoples and local communities. [2] | WIPO |
| WHO Traditional Medicine Strategy 2025 to 2034 | The strategy recognizes the importance of protecting traditional knowledge and promoting responsible use of natural resources. [1] | WHO |
What the research literature says
Two papers by an international group of researchers on biopiracy are a useful starting point. In one, the authors argue that patenting herbs or natural products disregarded the ownership of the knowledge Indigenous communities held about how these substances work. They add that, despite court decisions and international treaties, a rational sharing of benefits between producers and Indigenous communities "is yet a distant reality" (their assessment in 2016). [4] This is a concept and review paper, not a measurement, so treat it as expert opinion with a legal overview.In a later paper the group argued that standards are needed so traditional medicine can be used safely and fairly: sustainable production, quality control of herbal products, randomized clinical trials and phytovigilance (monitoring for harms). [5]
Why this matters when you read about a herb
- A traditional use is a gift of knowledge, not a free ingredient. Where a source says a plant was used by a named people, that history belongs to that people. This site describes traditions in their own terms and tries not to claim authority over them.
- Public and restricted knowledge differ. Our Therapies section explains what is public and what is restricted and why a published record is not an invitation to use it.
- Field research has its own best-practice guidance. A consensus statement aims to define best practice for developing, conducting and reporting field studies on local and traditional uses of plants. [6] How those studies are done is on the ethnobotany page.
- Demand can strain wild plants. NCCIH notes that wild goldenseal (Hydrastis canadensis) has been overharvested and is available in limited amounts. [7][8] See at-risk medicinal plants and conservation.
Frequently asked questions
What is biopiracy in herbal medicine?
It is a term for using biological resources or the knowledge of Indigenous or local communities without letting them share the benefits. Researchers describe it that way, and some use stronger language. [4][5]
What is the Nagoya Protocol?
It is a supplementary agreement to the Convention on Biological Diversity, adopted in 2010 and in force since 2014, about fair sharing of benefits from using genetic resources. It also covers associated traditional knowledge. [3]
Did the WIPO treaty of 2024 change anything for herbal products?
WIPO says its May 2024 treaty is the first to address intellectual property, genetic resources and associated traditional knowledge and to include provisions for Indigenous Peoples and local communities. [2] How it applies to a given herbal product is not described in the sources we read.
Does benefit sharing mean only money?
No. The CBD says benefits may be monetary or non-monetary, such as royalties and the sharing of research results. [3]
Can I tell from a label whether a herb was sourced fairly?
Not described in the sources we read. A label states species, part and amount; it does not show consent or benefit-sharing agreements. See reading an herbal supplement label.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Limits and uncertainty
- Proper evidence not found, in the sources we read, for how much money or other benefit has actually flowed back to communities from herbal products. We searched PubMed for biopiracy and benefit sharing and read the CBD, WIPO and WHO pages.
- We have not described individual patent or benefit-sharing cases, because we did not read primary sources on them.
- How each country puts the Nagoya Protocol into national law is not covered here. The sources we read say the protocol needs effective implementation at the domestic level. [3]
- Whether a particular herb on the market was obtained fairly cannot be told from its label.
Safety and who should ask a clinician
References
- World Health Organization (WHO). Traditional, Complementary and Integrative Medicine. Read 2026-10-23.
- World Intellectual Property Organization (WIPO). Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions. Read 2026-10-23.
- Secretariat of the Convention on Biological Diversity. About the Nagoya Protocol. Read 2026-10-23.
- Efferth T, Banerjee M, Paul NW, et al. Biopiracy of natural products and good bioprospecting practice. Phytomedicine. 2016;23(2):166-73. PMID 26926178. Read 2026-10-23.
- Efferth T, Banerjee M, Abu-Darwish MS, et al. Biopiracy versus One-World Medicine: from colonial relicts to global collaborative concepts. Phytomedicine. 2019;53:319-331. PMID 30190231. Read 2026-10-23.
- Best practice in research: Consensus Statement on Ethnopharmacological Field Studies (ConSEFS). J Ethnopharmacol. 2018. PMID 28818646. Read 2026-10-23.
- National Center for Complementary and Integrative Health (NCCIH). Goldenseal. Read 2026-10-23.
- GBIF Secretariat. GBIF Backbone Taxonomy. Names checked 2026-10-23 through the GBIF species match service (api.gbif.org).